GGrantIndex
Sort

51,593 grants matching hepatitis

HDAC1 as a nutrient sensor in the development and progression of NAFLD

$601,906
Hang Shi · Georgia State University · R01 · FY2022 · DK

Hepatic Tissue Integrity and Clonal Fitness: Key Factors in Controlling β-Catenin Induced Oncogenesis

$601,884
Joan Font-Burgada · Research Inst Of Fox Chase Can Ctr · R01 · FY2024 · CA

Understanding the Determinants of Racial/Ethnic Disparities in Liver Cancer and Chronic Liver Disease in Understudied and High-Risk Populations

$601,819
Veronica Wendy Setiawan · University Of Southern California · R01 · FY2018 · CA

Epigenetic Mechanisms Underlying Hepatitis C-Induced Hepatocarcinogenesis

$601,776
Keith D Robertson · Mayo Clinic Rochester · R01 · FY2018 · DK

Project 3 - Modulation of Antiviral Immunity and T cell Exhaustion by Inhibitory Receptors

$601,739
E. John Wherry · University Of Pittsburgh At Pittsburgh · P01 · FY2025 · AI

Neurobehavioral Deficits in HIV/HCV Infection Pre/Post Anti-HCV Therapy

$601,727
Charles H Hinkin · Brentwood Biomedical Research Institute · R01 · FY2009 · MH

Peripheral Reservoir of HIV DNA in Monocytes Pivotal to Cognition in HIV

$601,635
Victor Valcour · University Of California, San Francisco · R01 · FY2011 · NS

Quantitative Multimodal Image Guidance for Improved Liver Cancer Treatment

$601,618
James S Duncan · Yale University · R01 · FY2020 · CA

Defining the role of the RNA modification N6-methyladenosine during Flaviviridae virus infection

$601,615
Stacy Michelle Horner · Duke University · R01 · FY2024 · AI

Biomarkers to Identify Individuals at RIsk for Progression of S. Japonicum Associated Hepatic Fibrosis with Point of Care Test Development

$601,595
Jennifer F Friedman · Rhode Island Hospital · U01 · FY2024 · AI

Overriding the Immune Evasion Tactics of Coronavirus

$601,563
Carl F Ware · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2023 · AI

Overriding the Immune Evasion Tactics of Coronavirus

$601,563
Carl F Ware · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2024 · AI

Overriding the Immune Evasion Tactics of Coronavirus

$601,563
Carl F Ware · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2022 · AI

Defining the role of the RNA modification N6-methyladenosine during Flaviviridae virus infection

$601,533
Stacy Michelle Horner · Duke University · R01 · FY2023 · AI

Functional roles of Nrf2 and NQO1 genetic variants in hyperoxic lung injury-ARDS

$601,406
Bhagavatula Moorthy · Baylor College Of Medicine · R01 · FY2012 · HL

Biomarkers of Alcoholic Hepatitis

$601,401
Gavin E Arteel · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · AA

Sofosbuvir and Ledipasvir in HIV/HCV Coinfected Pre and Post Liver Transplant

$601,291
Peter G Stock · University Of California, San Francisco · U01 · FY2015 · AI

Programmed Differentiation Circuits for Organoids using Meso-Microfluidics

$601,284
Ron Weiss · Massachusetts Institute Of Technology · R01 · FY2018 · EB

Programmed Differentiation Circuits for Organoids using Meso-Microfluidics

$601,284
Ron Weiss · Massachusetts Institute Of Technology · R01 · FY2020 · EB

Programmed Differentiation Circuits for Organoids using Meso-Microfluidics

$601,284
Ron Weiss · Massachusetts Institute Of Technology · R01 · FY2019 · EB

Development of Dual Dopamine/Serotonin Releasing Agents

$601,275
Richard Rothman · National Institute On Drug Abuse · ZIA · FY2009 · DA

The STIRR Intervention for Dually Diagnosed Clients

$601,262
Dartmouth College · R01 · FY2005 · MH

Varenicline for the treatment of cocaine dependence: Phase II

$601,178
Jennifer Grace Plebani · University Of Pennsylvania · U01 · FY2014 · DA

Effect of SGLT2 inhibitors on hepatic glucose metabolism: role of autonomic nervous system

$601,089
Muhammad Abdul-Ghani · University Of Texas Hlth Science Center · R01 · FY2017 · DK

Effect of SGLT2 inhibitors on hepatic glucose metabolism: role of autonomic nervous system

$601,089
Muhammad Abdul-Ghani · University Of Texas Hlth Science Center · R01 · FY2018 · DK